Expert: results of an exit JOINT-STOCK COMPANY "ROSNANO" from "Nanolek" - an example of system effectiveness of state support
Show original
The director of RNC Pharma Rasshchupkin Pawel considers that this transaction will have positive impact on investment climate to Russian Federation...
Analysis
×
Anatoly Chubais
20Last position: Member of Presidium (ARVE)
Mikhail Nekrasov
Main activity:Official
Andrey Reus
Last position: Chairman of the board of directors (LLC "MBTS "Generium")
Rasshchupkin Pawel
JSC Rusnano
24Main activity:Communication and IT
Novartis Int AG
1Main activity:Health care and social services
LLC "Nanolek"
11Main activity:Science and education
Nanolek Holding Ltd
Organizations
Merck KGaA
Main activity:Health care and social services
Kirov region
340Regional centerKirov